PROSTATE-SPECIFIC ANTIGEN AND OTHER MARKERS OF THERAPEUTIC RESPONSE-Reference-Cited by-同舟云学术

PROSTATE-SPECIFIC ANTIGEN AND OTHER MARKERS OF THERAPEUTIC RESPONSE

Published:1999-05 Issue:2 Volume:26 Page:291-302
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Carducci Michael A.,DeWeese Theodore L.,Nelson Joel B.

Publisher

Elsevier BV

Subject

Urology

Reference83 articles.

1. Osteocalcin: Is it a useful marker of bone metastasis and response to treatment in advanced prostate cancer?;Arai;Prostate,1992

2. Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate;Angelsen;Prostate,1997

3. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies;Banks;Br J Cancer,1993

4. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis;Blitzer;Cancer,1985

5. Marimistat in patients with hormone refractory prostate cancer: A dose finding study;Boasberg;Proceedings of the American Society of Clinical Oncology,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twenty Years and Counting: Is PSA Still Useful in 2010?;Management of Prostate Cancer;2012

2. Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients;Asian Journal of Andrology;2009-02-02

3. Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?;Cancer;2007

4. Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: Modelization using a standardized set of response criteria;The Prostate;2007

5. Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases;The Prostate;2005-10-01